Skip to content

Head to head

enlighten III vs PicoSure (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview
Purchase cost
The catalog lists $90k–$130k for enlighten III. No new-price range is on file for PicoSure. Check the source notes and request current quotes.
Technology
enlighten III: Picosecond. PicoSure: Alexandrite.
Practice fit
Both are listed under picosecond tattoo/pigment. Check each model’s US regulatory status and labeled indications for your intended use.

Picosecond Tattoo/Pigment

View full device profile →

Picosecond Tattoo/Pigment

View full device profile →

Price comparison

New price range

Cutera enlighten III
$90k–$130kSource not documented
Cynosure PicoSure
Not published

Used asking range

Cutera enlighten III
$40k–$65kSource not documented
Cynosure PicoSure
$31,500–$105kReported source: Used listing · Aug 30, 2026

Payback calculator

Cutera enlighten III
View ROI calculator
Cynosure PicoSure
View ROI calculator

Next step

Cutera enlighten III
Cynosure PicoSure

Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.

Browse current models

Consumable economics

Consumable cost / lock-in

Cutera enlighten III
Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Cynosure PicoSure
Supply pricing is not documented with a dated source yet. Request an itemized supply quote. — no published lock — no electronic gating documented

Service cost

Cutera enlighten III
Not published
Cynosure PicoSure
Not published

FDA clearance

FDA status & indication

Cutera enlighten III
FDA ClearedK160488, K172077, K182997
Read FDA indication wording
The enlighten III laser system is intended for use in surgical and aesthetic applications in the medical specialties of dermatology and general and plastic surgery. 1064 nm: The 1064 nm wavelength of the enlighten III laser system is indicated for: • treatment of benign pigmented lesions on patients with all skin types (Fitzpatrick I-VI) • tattoo removal for dark colored tattoo inks and for multicolored tattoos containing dark colored tattoo inks on patients with all skin types (Fitzpatrick I-VI) 532 nm: The 532 nm wavelength of the enlighten III laser system is indicated for: • treatment of benign pigmented lesions on patients with Fitzpatrick skin types I-III • tattoo removal for lighter colored tattoo inks, including red and yellow inks, on patients with Fitzpatrick skin types I-III 670 nm: The 670 nm wavelength of the enlighten III laser system is indicated for treatment of benign pigmented lesions on patients with Fitzpatrick skin types I-III.
Cynosure PicoSure
FDA ClearedK121346, K133364
Read FDA indication wording
The PicoSure™ workstation is indicated for tattoo and benign pigmented lesions removal.

Which chains run each

Chain adoption

Cutera enlighten III
0 recorded pairings
Cynosure PicoSure
0 recorded pairings

Chains using it

Cutera enlighten III
Cynosure PicoSure

Approved reviews

Cutera enlighten III
0
Cynosure PicoSure
0

Specs and platform

Manufacturer

Cutera enlighten III
Cutera
Cynosure PicoSure
Cynosure

Built by (OEM)

Cutera enlighten III
Cutera Inc.
Cynosure PicoSure
Cynosure LLC

Category

Cutera enlighten III
Picosecond Tattoo/Pigment
Cynosure PicoSure
Picosecond Tattoo/Pigment

Technology

Cutera enlighten III
532/670/1064nm pico+nano (Picosecond)
Cynosure PicoSure
755nm picosecond alexandrite (Alexandrite)

Launch year

Cutera enlighten III
2017
Cynosure PicoSure
2013

Status

Cutera enlighten III
Current
Cynosure PicoSure
Legacy-used-market

Manufacturer source record

Cutera enlighten III
No linked source on file.
Cynosure PicoSure
No linked source on file.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.